Literature DB >> 10903237

Respiratory viral infections in adults with and without chronic obstructive pulmonary disease.

S B Greenberg1, M Allen, J Wilson, R L Atmar.   

Abstract

A longitudinal cohort study of older adults with chronic obstructive pulmonary disease (COPD) who were stratified by FEV(1) at enrollment was done to define the etiology, frequency, severity, and medical-care impact of respiratory tract viral infections (RTVIs). Controls consisted of a group of subjects of comparable age with the patients. RTVIs were documented in 44% of observed acute respiratory illnesses in control subjects and in 27% of COPD subjects, who were followed for mean periods of 35 and 26 mo, respectively. In this heavily influenza-vaccinated cohort ( approximately 90% vaccinated each year), picornaviruses, parainfluenza viruses, and coronaviruses were most commonly identified. Mean time to return to clinical baseline was approximately 2 wk in each group. Control and COPD subjects with mild airways obstruction (baseline FEV(1) >/= 50% predicted) had few emergency-center visits or hospitalizations. Approximately half of COPD subjects with moderate/severe COPD (baseline FEV(1) < 50% predicted) had at least one emergency-center visit and/or hospitalization for acute respiratory illness. RTVIs were documented in 23% of hospitalizations and in 45% of patients admitted between December and March. RTVIs have a major impact on utilization of health care resources for COPD patients with moderate/severe airways obstruction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903237     DOI: 10.1164/ajrccm.162.1.9911019

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  89 in total

Review 1.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.

Authors:  Vasile Laza-Stanca; Luminita A Stanciu; Simon D Message; Michael R Edwards; James E Gern; Sebastian L Johnston
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 4.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

5.  Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Authors:  Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

6.  Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Carlos A Camargo; Adit A Ginde; Sunday Clark; Charles P Cartwright; Ann R Falsey; Dennis E Niewoehner
Journal:  Intern Emerg Med       Date:  2008-09-30       Impact factor: 3.397

7.  Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.

Authors:  Manisha Singh; Seung-Hyo Lee; Paul Porter; Chuang Xu; Ayako Ohno; Robert L Atmar; Stephen B Greenberg; Venkata Bandi; Jim Gern; Svetlana Amineva; Alex Aminev; Tim Skern; Pamela Smithwick; Sarah Perusich; Nadia Barrow; Luz Roberts; David B Corry; Farrah Kheradmand
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

Review 8.  Current research on respiratory viral infections: Fourth International Symposium.

Authors:  Michael G Ison; John Mills; Peter Openshaw; Maria Zambon; Albert Osterhaus; Frederick Hayden
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

9.  Rhinovirus disrupts the barrier function of polarized airway epithelial cells.

Authors:  Umadevi Sajjan; Qiong Wang; Ying Zhao; Dieter C Gruenert; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

Review 10.  Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation.

Authors:  J R Hurst; J A Wedzicha
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.